Comparative Pharmacology
Head-to-head clinical analysis: NUTRACORT versus TOPICORT LP.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NUTRACORT versus TOPICORT LP.
NUTRACORT vs TOPICORT LP
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Corticosteroid receptor agonist; induces anti-inflammatory proteins and suppresses inflammatory mediators.
Topicort LP (desoximetasone) is a corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It binds to intracellular glucocorticoid receptors, leading to modulation of gene expression that suppresses inflammatory mediators such as prostaglandins, leukotrienes, and cytokines.
One capsule (200 mg) orally twice daily with meals.
Apply a thin film to the affected skin areas twice daily. Route: topical. Frequency: twice daily.
None Documented
None Documented
Terminal half-life: 2-4 hours (mean 3 hours). Clinically, dosing every 6-8 hours maintains therapeutic levels.
Terminal elimination half-life is approximately 2-4 hours after topical application. This short half-life reflects rapid systemic clearance and minimal accumulation with once-daily dosing.
Renal (primarily as glucuronide and sulfate conjugates, <10% unchanged) and fecal (biliary excretion of metabolites). Approximately 70-80% renal, 20-30% fecal.
Primarily renal (urinary excretion of metabolites and unchanged drug). Biliary/fecal elimination is minimal, accounting for <5% of the dose.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid